Study of the efficacy and safety of ramelteon in insomnia of diabetes merger under the medical treatment of cancer patients
Not Applicable
- Conditions
- Insomnia cancer patients under the medical treatment to be complicated by diabetes
- Registration Number
- JPRN-UMIN000014162
- Lead Sponsor
- Division of Diabetes, Endocrinology and Metabolism, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with hypersensitivity to Rozerem. Patients with advanced liver dysfunction. Patient during administration of fluvoxamine maleate.
Study & Design
- Study Type
- Interventional,observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sleep evaluation questionnaire
- Secondary Outcome Measures
Name Time Method